Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 62401-62450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06055244
Amantadine Therapy for Cognitive Impairment in Long COVID
PHASE2Recruiting
60 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05440032
LE as a Marker for Periprosthetic Joint Infection
N/ARecruiting
160 participants
Started: Dec 7, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor8 locations
NCT06869603
Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic
N/ARecruiting
50 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05578495
Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB)
NARecruiting
700 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2030
7 conditions1 sponsor1 location
NCT05917522
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
PHASE2Recruiting
800 participants
Started: Dec 7, 2023 · Completed: Jul 31, 2029
1 condition1 sponsor15 locations
NCT06234436
Plasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI)
EARLY_PHASE1Enrolling by invitation
10 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05670158
Immunity After Cochlear Implantation and Perilymph Molecular Profiles in Sensorineural Hearing Loss
NARecruiting
80 participants
Started: Dec 7, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05983991
Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation
NARecruiting
150 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2033
1 condition1 sponsor19 locations
NCT05440422
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
PHASE2Recruiting
45 participants
Started: Dec 7, 2023 · Completed: Aug 1, 2026
3 conditions1 sponsor1 location
NCT05930093
Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects
NARecruiting
108 participants
Started: Dec 7, 2023 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT06278818
Effects of Telerehabilitation on Brain Network Connectivity
NARecruiting
110 participants
Started: Dec 7, 2023 · Completed: Mar 1, 2026
1 condition4 sponsors1 location
NCT06143839
VYxeoS Liposomal Italian Observational Study iN the Real Practice
N/AActive, not recruiting
112 participants
Started: Dec 7, 2023 · Completed: Feb 1, 2026
3 conditions2 sponsors24 locations
NCT06144632
A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF
NAActive, not recruiting
237 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor29 locations
NCT06153277
Does Edema Affect the Adjustment of TENS Amplitude
N/ARecruiting
125 participants
Started: Dec 7, 2023 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT05653063
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
N/ARecruiting
990 participants
Started: Dec 7, 2023 · Completed: Sep 1, 2026
3 conditions14 sponsors6 locations
NCT06205927
Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer
PHASE2Recruiting
77 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05983029
Determination of Utility of Intergluteal Cleft as Landmark for Neuraxial Midline in Obstetrics
N/ARecruiting
99 participants
Started: Dec 7, 2023 · Completed: Sep 1, 2024
1 condition1 sponsor1 location
NCT06168708
The Safety and Efficacy of Addition of Gentamicin on Irrigation Fluid in Prevention of Post-Transurethral Resection of the Prostate Infectious Complications.
NARecruiting
220 participants
Started: Dec 7, 2023 · Completed: Jul 7, 2024
1 condition1 sponsor1 location
NCT05988411
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation Vs Control in Redo Ablation Patients
NARecruiting
250 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor8 locations
NCT06303050
Additional Effects of Mental Imagery Along With Task Oriented Training on Kinesiophobia in Patients With Stroke
NARecruiting
44 participants
Started: Dec 7, 2023 · Completed: Jun 7, 2024
1 condition1 sponsor1 location
NCT05819814
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
NARecruiting
200 participants
Started: Dec 7, 2023 · Completed: Feb 1, 2027
1 condition2 sponsors1 location
NCT05850091
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
PHASE4Recruiting
200 participants
Started: Dec 7, 2023 · Completed: Feb 1, 2027
1 condition2 sponsors1 location
NCT06052384
Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists
NARecruiting
664 participants
Started: Dec 7, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06463925
Evaluation of Effaclar Duo+M on Acne Lesions in Subjects With Mild to Moderate Acne on Face and Trunk
NARecruiting
65 participants
Started: Dec 7, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06178315
EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
NARecruiting
94 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06223048
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
PHASE2Recruiting
50 participants
Started: Dec 7, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor3 locations
NCT06148272
A Study of LY3971297 in Healthy Participants
PHASE1Recruiting
225 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor6 locations
NCT06181136
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Dec 7, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor4 locations
NCT05936710
Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite Using Citrate- vs Acetate-based Dialysate
NARecruiting
48 participants
Started: Dec 7, 2023 · Completed: Jan 4, 2025
1 condition2 sponsors2 locations
NCT05460611
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
NARecruiting
10 participants
Started: Dec 7, 2023 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT06108648
Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis
PHASE4Recruiting
400 participants
Started: Dec 7, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor2 locations
NCT06051006
The Value Electrical Stapedial Reflex Thresholds (eSRTs) Cochlear Implant Mapping
N/ARecruiting
30 participants
Started: Dec 7, 2023 · Completed: Jan 7, 2026
2 conditions2 sponsors1 location
NCT05798663
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
PHASE2Active, not recruiting
178 participants
Started: Dec 7, 2023 · Completed: Nov 30, 2026
1 condition2 sponsors15 locations
NCT06150014
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
PHASE1/PHASE2Active, not recruiting
88 participants
Started: Dec 7, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor3 locations
NCT05956041
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
PHASE2Recruiting
23 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05888688
The Sarcopenia Study
N/ARecruiting
80 participants
Started: Dec 6, 2023 · Completed: Sep 1, 2026
6 conditions1 sponsor1 location
NCT06177522
Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
PHASE2Recruiting
30 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06687447
The Effect of Two Methods Applied to Mothers on Insufficient Milk Perception, Breastfeeding Motivation, Fatigue, Anxiety
NARecruiting
90 participants
Started: Dec 6, 2023 · Completed: Jul 6, 2025
1 condition1 sponsor1 location
NCT06125704
Time to Move in Pregnancy Hyperglycemia
NARecruiting
36 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2025
6 conditions2 sponsors1 location
NCT05722327
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
PHASE1Active, not recruiting
24 participants
Started: Dec 6, 2023 · Completed: Sep 30, 2027
2 conditions2 sponsors1 location
NCT05782127
Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
PHASE1/PHASE2Recruiting
36 participants
Started: Dec 6, 2023 · Completed: Nov 30, 2028
1 condition3 sponsors25 locations
NCT06430931
Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery
NARecruiting
184 participants
Started: Dec 6, 2023 · Completed: Jul 1, 2026
11 conditions2 sponsors1 location
NCT06041321
Novel Bioactive Sleeve on Pain and PROMs
NARecruiting
100 participants
Started: Dec 6, 2023 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT05836584
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
PHASE2Active, not recruiting
240 participants
Started: Dec 6, 2023 · Completed: Oct 31, 2027
10 conditions1 sponsor133 locations
NCT06069830
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
NARecruiting
89 participants
Started: Dec 6, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06187779
Induction ATAD Catheter and Lower Segment Thickness
NAActive, not recruiting
500 participants
Started: Dec 6, 2023 · Completed: Dec 6, 2026
1 condition1 sponsor1 location
NCT06077760
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
PHASE3Recruiting
868 participants
Started: Dec 6, 2023 · Completed: Dec 21, 2035
1 condition2 sponsors213 locations
NCT06141850
Promoting Engagement and COVID-19 Testing for Health
NAActive, not recruiting
284 participants
Started: Dec 6, 2023 · Completed: Aug 31, 2025
1 condition4 sponsors1 location
NCT06040112
Effect of Atelocollagen Injection in Patients With Calcific Tendinitis
PHASE4Recruiting
46 participants
Started: Dec 6, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT05994625
Economic Evaluation of Stream™ Platform
PHASE3Active, not recruiting
215 participants
Started: Dec 6, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors2 locations